ANAL CARCINOMA
Clinical trials for ANAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested for hard-to-treat cancers
Disease control TerminatedThis study tested an experimental drug called INCB099318 in 105 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are limited…
Matched conditions: ANAL CARCINOMA
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 26, 2026 08:40 UTC
-
Immunotherapy duo shows promise for HIV cancer patients
Disease control TerminatedThis early-stage study tested two immunotherapy drugs, ipilimumab and nivolumab, in 79 people with HIV who also had advanced solid tumors or Hodgkin lymphoma. The goal was to find the safest dose and see if the combination could shrink tumors. The trial was stopped early, but res…
Matched conditions: ANAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:54 UTC